CD30 ligand is expressed on resting normal and malignant human B lymphocytes

British Journal of Haematology

Volumn 93, Issue 3, 1996, Pages 569-571

  Younes, Anas ^a,c   Consoli, Ugo ^a   Zhao, Shourong ^a   Snell, Virginia ^a   Thomas, Elaine ^b   Gruss, Hans J ^b   Cabanillas, Fernando ^a   Andreeff, Michael ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD30L; CLL; FACScan; Lymphocytes; RT PCR

Indexed keywords

CD30 ANTIGEN; CD30 LIGAND; UNCLASSIFIED DRUG;

ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029948637     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1686.x     Document Type: Article

References (12)

1. Armitage, R.J. (1994) Tumor necrosis factor receptor superfamily members and their ligands. Current Opinion in Immunology, 6, 407-413.
2. Beutler, B. & van Huffel, C. (1994) Unraveling function in the TNF ligand and receptor families. Science, 264, 667-668.
3. Del Prete, G., Maggi, E., Pizzolo, G. & Romagnani, S. (1995) CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunology Today, 16, 76-80.
4. + T cells. Journal of Immunology, 151, 2380-2389.
5. Falini, B., Pileri, S., Pizzolo, G., Dürkop, H., Flenghi, L., Stirpe, F., Martelli, M.F. & Stein, H. (1995) CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood, 85, 1-14.
6. Gruss, H.J., Boiani, N., Williams, D.E., Armitage, R.J., Smith, C.A. & Goodwin, R.G. (1994) Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood, 83, 2045-2056.
7. Haluska, P., Brufsky, A.M. & Canellos, G.P. (1994) The cellular biology of the Reed-Sternberg cell. Blood, 84, 1005-1019.
8. + malignant lymphomas. Critical Reviews in Oncology, 4, 191-239.
9. Hintzen, R.Q., Lens, S.M., Beckmann, M.P., Goodwin, R.G., Lynch, D. & Van Lier, R.A. (1994) Characterization of the human CD27 ligand, a novel member of the TNF gene family. Journal of Immunology, 152, 1762-1773.
10. Smith, C.A., Farrah, T. & Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell, 76, 959-962.
11. Smith, C.A., Gruss, H.J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G.R., Brannan, C.I., Copeland, N.G. & Armitage, R.J. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell, 73, 1349-1360.
12. Younes, A., Zhao, S., Jendiroba, D., Klein, H., Cabanillas, F. & Andreeff, M. (1995) Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma. Blood, 85, 2813-2816.